Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 312,772 | reported | 02 Feb 2026 | tx 13+985,950−123,060 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 13,382 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 36,142 | 1.39 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 79,000 | 0.00 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 119,000 | 0.00 USD | deriv |
| 09 Jun 2025 | SALE | Akebia Therapeutics, Inc. | 15,000 | 4.01 USD | |
| 09 Jun 2025 | EXERCISE | Akebia Therapeutics, Inc. | 15,000 | 1.68 USD | |
| 09 Jun 2025 | EXERCISE | Akebia Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 04 Jun 2025 | SALE | Akebia Therapeutics, Inc. | 13,334 | 3.53 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 85,000 | 0.00 USD | |
| 03 Feb 2025 | SALE | Akebia Therapeutics, Inc. | 30,202 | 2.10 USD | |
| 31 Jan 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 128,000 | 0.00 USD | deriv |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 223,950 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 336,000 | 0.00 USD | deriv |